CSC
MACK

Caldwell Sutter Capital’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Caldwell Sutter Capital’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-7,458
Closed – – 939
2024
Q2 		$0 Buy
+7,458
New – ﹤0.01% 954